Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02431793 · ClinicalTrials.gov registry record · NA
EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use
A NA study of Opioid Use, Unspecified, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 652
- Enrollment target
- 1
- Study location
NCT02431793: Completed NA study of Opioid Use, Unspecified, sponsored by Northwestern University.
NCT02431793 is a NA study of Opioid Use, Unspecified that has completed, run by Northwestern University. The registered enrollment target is 652 participants, above the 155-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (321% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02431793, a NA study of Opioid Use, Unspecified, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 652 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effectiveness of an electronic health record based strategy in promoting safe use of opioid medications after an Emergency Department (ED) visit. The electronic health record (EHR)-based strategy was designed to enhance provider counseling about opioids and to standardize and simplify the information that patients receive.
Primary Outcome
Patient's ability to demonstrate correctly dosing their prescription opioid-acetaminophen pain reliever will be assessed through a series of questions. Correct dosing will be scored for each medication as yes/no reflecting having demonstrated all of the following: proper dose (# of pills), appropriate spacing (hours between doses), and total daily dose (not exceeding recommended daily dose).
Conditions Studied
Interventions
- BEHAVIORAL EMC2 Strategy
- BEHAVIORAL SMS Text Reminders
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 652 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-09 |
| Phase | NA |
What the finished NCT02431793 record still lists
NCT02431793 is an interventional study that assigns participants to a tested intervention. The registered 652 participants enrollment target is mid-sized for trials with a published cap, above the 155-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (321% higher).
The record links to 1 condition, with Opioid Use, Unspecified appearing as the primary indexed condition, and to 2 interventions - of which EMC2 Strategy is the first listed.
NCT02431793 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02431793 about?
NCT02431793 is a clinical study titled "EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use". The purpose of this study is to test the effectiveness of an electronic health record based strategy in promoting safe use of opioid medications after an Emergency Department (ED) visit. The electronic health record (EHR)-based strategy was designed to enhance provider counseling about opioids and t...
What is the current status of trial NCT02431793?
This trial is currently completed. It is a NA study. The enrollment target is 652 participants. The study started on 2015-07. Estimated completion is 2018-09.
What conditions does trial NCT02431793 study?
This clinical trial studies the following conditions: Opioid Use, Unspecified.
What interventions are being tested in trial NCT02431793?
The interventions under investigation include: EMC2 Strategy (BEHAVIORAL), SMS Text Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT02431793?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02431793 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use, Unspecified
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02431793's enrollment target sits among peer trials
652 1st of 9 higher than 9 of 9 other Opioid Use, Unspecified trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use, Unspecified trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Utilization of Opioid Destruction Bags in the Post-op Period
ACTIVE NOT RECRUITING · NA
-
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
COMPLETED · NA
-
Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase
COMPLETED · NA
-
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
COMPLETED · NA
-
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
RECRUITING
-
Sensory Outcomes in Active Substance Users
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06287346 · 652 participants
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia